Stay updated on Decitabine+Tetrahydrouridine in Lung/Esophageal Ca Immunotherapy Clinical Trial
Sign up to get notified when there's something new on the Decitabine+Tetrahydrouridine in Lung/Esophageal Ca Immunotherapy Clinical Trial page.

Latest updates to the Decitabine+Tetrahydrouridine in Lung/Esophageal Ca Immunotherapy Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedCore page content updated with a government operating-status notice and a version upgrade to v3.2.0; a specific resource reference (Carcinoma of esophagus) was removed.SummaryDifference2%
- Check24 days agoChange DetectedThe page now references revision v3.1.0 instead of v3.0.2, indicating an update to the version metadata. No other substantive content changes are indicated.SummaryDifference0.0%
- Check38 days agoChange DetectedVersion bumped from v3.0.1 to v3.0.2. The 'Back to Top' link was removed, a minor navigational change.SummaryDifference0.1%
- Check45 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content or other important factors.SummaryDifference0.1%
- Check52 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as new topics related to esophageal cancer and various chemical compounds. Notably, several previous topics and terms related to lung cancer and antineoplastic agents have been removed.SummaryDifference3%
- Check67 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.0%
Stay in the know with updates to Decitabine+Tetrahydrouridine in Lung/Esophageal Ca Immunotherapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Decitabine+Tetrahydrouridine in Lung/Esophageal Ca Immunotherapy Clinical Trial page.